1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. BREAST IMAGING MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Mammography
5.3. Ultrasound
5.4. Magnetic Resonance Imaging (MRI)
5.5. Nuclear Imaging
5.6. Others
6. BREAST IMAGING MARKET BY PROCEDURE
6.1. Introduction
6.2. Screening Mammography
6.3. Diagnostic Mammography
6.4. Breast Tomosynthesis
6.5. Breast Ultrasound
6.6. Breast MRI
6.7. Others
7. BREAST IMAGING MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic Centers
7.4. Research Laboratories
8. BREAST IMAGING MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Australia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. GE Healthcare
10.2. Hologic, Inc.
10.3. Siemens Healthineers AG
10.4. Koninklijke Philips N.V.
10.5. Fujifilm Holdings Corporation
10.6. Canon Medical Systems Corporation
10.7. Dilon Technologies, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES